TieMed

TieMed was a small private biotechnology/specialty pharmaceutical company based in Princeton, New Jersey that focused on developing easier-to-take oral medicines for patients who have difficulty swallowing tablets. Its core approach was an effervescent tablet formulation and manufacturing process intended to fully dissolve high-volume prescription drugs in water, with the goal of improving adherence, persistence, and clinical outcomes. Publicly available startup materials identify metformin for Type 2 diabetes as its lead development program. The company appears to have remained at an early product-development stage with a very small team, and there is no clear evidence of clinical advancement, commercialization, acquisition, or ongoing current operations.